UK Markets closed

Global Preimplantation Genetic Testing Market to Reach $775.1 Million by 2027

·24-min read

Abstract: - Global Preimplantation Genetic Testing Market to Reach $775. 1 Million by 2027. - Amid the COVID-19 crisis, the global market for Preimplantation Genetic Testing estimated at US$434.

New York, July 07, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Preimplantation Genetic Testing Industry" - https://www.reportlinker.com/p06032644/?utm_source=GNW
6 Million in the year 2020, is projected to reach a revised size of US$775.1 Million by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. Reagents & Consumables, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$408.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $128.7 Million, While China is Forecast to Grow at 8% CAGR
- The Preimplantation Genetic Testing market in the U.S. is estimated at US$128.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$134.4 Million by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.
- Software & Services Segment to Record 8.3% CAGR
- In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 8.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$72.9 Million in the year 2020 will reach a projected size of US$128 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$89.4 Million by the year 2027.

- Select Competitors (Total 34 Featured) -

  • Ariosa Diagnostics

  • Bioarray S.L.

  • California Pacific Medical Center (CPMC)

  • CombiMatrix

  • CooperSurgical, Inc.

  • F. Hoffmann-La Roche Ltd.

  • Genea Limited

  • Genesis Genetics

  • Good Start Genetics, Inc.

  • IGENOMIX

  • Illumina, Inc.

  • Invitae Corporation

  • Laboratory Corporation of America Holdings

  • Natera, Inc.

  • Oxford Gene Technology

  • PerkinElmer Inc.

  • Quest Diagnostics Incorporated

  • Reproductive Genetic Innovations, LLC

  • Reprogenetics

  • RHS Ltd.

  • Sequenom

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p06032644/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Preimplantation
Genetic Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Preimplantation Genetic
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 3: World 15-Year Perspective for Preimplantation Genetic
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Reagents &
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 5: World Historic Review for Reagents & Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Reagents & Consumables
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Software &
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Software & Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Software & Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Research
Laboratories & Academic Institutes by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Research Laboratories &
Academic Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Research Laboratories &
Academic Institutes by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Maternity Centers &
Fertility Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Maternity Centers &
Fertility Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Maternity Centers &
Fertility Clinics by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals,
Diagnostic Labs & Service Providers by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals, Diagnostic Labs &
Service Providers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hospitals, Diagnostic
Labs & Service Providers by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Next Generation
Sequencing (NGS) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Next Generation Sequencing
(NGS) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Next Generation
Sequencing (NGS) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Polymerase Chain
Reaction (PCR) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Polymerase Chain Reaction
(PCR) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Polymerase Chain
Reaction (PCR) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Fluorescent
In-Situ Hybridization (FISH) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Fluorescent In-Situ
Hybridization (FISH) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Fluorescent In-Situ
Hybridization (FISH) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Other
Technologies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 32: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 34: USA Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: USA Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Preimplantation Genetic
Testing by Component - Percentage Breakdown of Value Sales for
Reagents & Consumables, Instruments and Software & Services for
the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Preimplantation Genetic
Testing by End-Use - Percentage Breakdown of Value Sales for
Research Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers for the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Preimplantation
Genetic Testing by Technology - Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 41: USA Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Preimplantation Genetic
Testing by Technology - Percentage Breakdown of Value Sales for
Next Generation Sequencing (NGS), Polymerase Chain Reaction
(PCR), Fluorescent In-Situ Hybridization (FISH) and Other
Technologies for the Years 2012, 2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: Canada Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 47: Canada Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Preimplantation
Genetic Testing by Technology - Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 50: Canada Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2020 & 2027

JAPAN
Table 52: Japan Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 53: Japan Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Preimplantation Genetic
Testing by Component - Percentage Breakdown of Value Sales for
Reagents & Consumables, Instruments and Software & Services for
the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: Japan Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Preimplantation Genetic
Testing by End-Use - Percentage Breakdown of Value Sales for
Research Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers for the Years 2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Preimplantation
Genetic Testing by Technology - Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 59: Japan Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Preimplantation Genetic
Testing by Technology - Percentage Breakdown of Value Sales for
Next Generation Sequencing (NGS), Polymerase Chain Reaction
(PCR), Fluorescent In-Situ Hybridization (FISH) and Other
Technologies for the Years 2012, 2020 & 2027

CHINA
Table 61: China Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: China Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Preimplantation Genetic
Testing by Component - Percentage Breakdown of Value Sales for
Reagents & Consumables, Instruments and Software & Services for
the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 65: China Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Preimplantation Genetic
Testing by End-Use - Percentage Breakdown of Value Sales for
Research Laboratories & Academic Institutes, Maternity Centers &
Fertility Clinics and Hospitals, Diagnostic Labs & Service
Providers for the Years 2012, 2020 & 2027

Table 67: China Current & Future Analysis for Preimplantation
Genetic Testing by Technology - Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 68: China Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Preimplantation Genetic
Testing by Technology - Percentage Breakdown of Value Sales for
Next Generation Sequencing (NGS), Polymerase Chain Reaction
(PCR), Fluorescent In-Situ Hybridization (FISH) and Other
Technologies for the Years 2012, 2020 & 2027

EUROPE
Table 70: Europe Current & Future Analysis for Preimplantation
Genetic Testing by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Preimplantation Genetic
Testing by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Preimplantation
Genetic Testing by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: Europe Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 77: Europe Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Preimplantation
Genetic Testing by Technology - Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 80: Europe Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2020 & 2027

FRANCE
Table 82: France Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: France Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: France Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2020 & 2027

Table 88: France Current & Future Analysis for Preimplantation
Genetic Testing by Technology - Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 89: France Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2020 & 2027

GERMANY
Table 91: Germany Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Germany Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 95: Germany Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Preimplantation
Genetic Testing by Technology - Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 98: Germany Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 99: Germany 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2020 & 2027

ITALY
Table 100: Italy Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: Italy Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Preimplantation
Genetic Testing by Component - Percentage Breakdown of Value
Sales for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 104: Italy Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Preimplantation
Genetic Testing by End-Use - Percentage Breakdown of Value
Sales for Research Laboratories & Academic Institutes,
Maternity Centers & Fertility Clinics and Hospitals, Diagnostic
Labs & Service Providers for the Years 2012, 2020 & 2027

Table 106: Italy Current & Future Analysis for Preimplantation
Genetic Testing by Technology - Next Generation Sequencing
(NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 107: Italy Historic Review for Preimplantation Genetic
Testing by Technology - Next Generation Sequencing (NGS),
Polymerase Chain Reaction (PCR), Fluorescent In-Situ
Hybridization (FISH) and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 108: Italy 15-Year Perspective for Preimplantation
Genetic Testing by Technology - Percentage Breakdown of Value
Sales for Next Generation Sequencing (NGS), Polymerase Chain
Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and
Other Technologies for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 109: UK Current & Future Analysis for Preimplantation
Genetic Testing by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 110: UK Historic Review for Preimplantation Genetic
Testing by Component - Reagents & Consumables, Instruments and
Software & Services Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Preimplantation Genetic
Testing by Component - Percentage Breakdown of Value Sales for
Reagents & Consumables, Instruments and Software & Services for
the Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Preimplantation
Genetic Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 113: UK Historic Review for Preimplantation Genetic
Testing by End-Use - Research Laboratories & Academic
Institutes, Maternity Centers & Fertility Clinics and
Hospitals, Diagnostic Labs & Service Providers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 114: UK 15-Year Perspective for Preimplantation Genetic
Testing by End-Use - Percentage Breakdown of Value Sales for

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032644/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting